6 Israeli Breakthroughs In Cancer Research – NoCamels Team
Although hundreds of projects and trials are still ongoing, here are five recent developments in cancer research and treatment from Israel so far this year.
1. Israeli researchers kill a cancerous tumor with synthetic cells
Israeli scientists have successfully treated a cancerous tumor, eradicating its cancer cells using a “nano-factory” – a synthetic cell that produces anti-cancer proteins within the tissue. Synthetic cells, “are artificial systems with capacities similar to, and, at times, superior to those of natural cells,”says the Technion-Israel Institute of Technology.
“The artificial cells we’ve developed at the Technion may take an important part in the personalized medicine trend – adjustment of treatment to the genetic and medical profile of a specific patient,” Assistant Professor Avi Schroeder at the Wolfson Faculty of Chemical Engineering at the Technion who co-led the research with doctoral student Nitzan Krinsky said.
2. Harnessing light and gold for drug-delivery in treatments including cancer
Israeli scientists have developed technology that enables drug delivery to target diseased tissue only, using light and gold particles, which can be used to make cancer treatments, for example, more effective.
The system harnesses the particles to specifically target the affected tissue, like a tumor, rather than dispersed throughout the body which is often harmful, the university said.
Researchers at Tel Aviv University said they concluded a study that “may serve as a basis for the development of an effective cocktail of drugs for this deadly disease and other cancers.”
The scientists were able to devise “a novel nanoparticle that selectively delivers genetic material to a tumor and prevents side effects in surrounding healthy tissues,” the university said.
4. New non-invasive test developed for prostate cancer
Israeli company developed technology for a new non-invasive diagnostic test for prostate cancer, the second most common cancer in men worldwide.
5. Israeli company announces new clinical trial for breast cancer blood test
Todos Medical Ltd announced that it was conducted its first blinded clinical trial for a blood test for breast cancer screening at Kaplan Medical Center in Rehovot.
6. Israeli-founded social network for cancer patients and caregivers announces new partnerships in North America
The Israeli-founded social network for cancer patients and caregivers, Belong, announced that it was partnering Colorectal Cancer Canada (CCC), to “improve the quality of life for colorectal cancer patients and their families by increasing access to high-quality content, digital services and community support.”
Belong developed a free, AI-powered app that provides people with cancer and their families an effective, up-to-date channel and “a unique and innovative personalized solution to help manage and fight cancer more effectively.”